Yoshihiro Arai
Chief Executive Officer at SOLASIA PHARMA K.K.
Net worth: 251 737 $ as of 30/03/2024
Profile
Yoshihiro Arai is currently the President, CEO & Representative Director at Solasia Pharma KK since 2013.
Previously, he worked as a Principal at Amgen KK and Searle Yakuhin KK.
He holds an MBA from the University of Wales (Bangor) and has undergraduate and graduate degrees from Tokyo University of Pharmacy & Life Science.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SOLASIA PHARMA KK
0.65% | 30/12/2023 | 1,154,545 ( 0.65% ) | 251 737 $ | 30/03/2024 |
Yoshihiro Arai active positions
| Companies | Position | Start |
|---|---|---|
| SOLASIA PHARMA K.K. | Chief Executive Officer | 31/01/2013 |
Former positions of Yoshihiro Arai
| Companies | Position | End |
|---|---|---|
| Searle Yakuhin KK | Corporate Officer/Principal | - |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The private company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Corporate Officer/Principal | - |
Training of Yoshihiro Arai
| University of Wales (Bangor) | Masters Business Admin |
| Tokyo University of Pharmacy & Life Science | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SOLASIA PHARMA K.K. | Health Technology |
| Private companies | 2 |
|---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The private company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
| Searle Yakuhin KK |
- Stock Market
- Insiders
- Yoshihiro Arai
